DOCSLIB.ORG

Clinical Trials

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Clinical Trials House of Commons Science and Technology Committee Clinical trials Third Report of Session 2013–14 Report, together with formal minutes, oral and written evidence Additional written evidence is contained in Volume II, available on the Committee website at www.parliament.uk/science Ordered by the House of Commons to be printed 9 September 2013 HC 104 [Incorporating HC 1054-i and ii, Session 2012–13] Published on 17 September 2013 by authority of the House of Commons London: The Stationery Office Limited £22.00 Science and Technology Committee The Science and Technology Committee is appointed by the House of Commons to examine the expenditure, administration and policy of the Government Office for Science and associated public bodies. Current membership Andrew Miller (Labour, Ellesmere Port and Neston) (Chair) Jim Dowd (Labour, Lewisham West and Penge) Stephen Metcalfe (Conservative, South Basildon and East Thurrock) David Morris (Conservative, Morecambe and Lunesdale) Stephen Mosley (Conservative, City of Chester) Pamela Nash (Labour, Airdrie and Shotts) Sarah Newton (Conservative, Truro and Falmouth) Graham Stringer (Labour, Blackley and Broughton) David Tredinnick (Conservative, Bosworth) Hywel Williams (Plaid Cymru, Arfon) Roger Williams (Liberal Democrat, Brecon and Radnorshire) The following members were also members of the committee during the parliament: Gavin Barwell (Conservative, Croydon Central) Caroline Dinenage (Conservative, Gosport) Gareth Johnson (Conservative, Dartford) Gregg McClymont (Labour, Cumbernauld, Kilsyth and Kirkintilloch East) Stephen McPartland (Conservative, Stevenage) Jonathan Reynolds (Labour/Co-operative, Stalybridge and Hyde) Powers The Committee is one of the departmental Select Committees, the powers of which are set out in House of Commons Standing Orders, principally in SO No.152. These are available on the Internet via www.parliament.uk Publications The Reports and evidence of the Committee are published by The Stationery Office by Order of the House. All publications of the Committee (including press notices) are on the Internet at http://www.parliament.uk/science. A list of reports from the Committee in this Parliament is included at the back of this volume. The Reports of the Committee, the formal minutes relating to that report, oral evidence taken and some or all written evidence are available in printed volume(s). Additional written evidence may be published on the internet only. Committee staff The current staff of the Committee are: Dr Stephen McGinness (Clerk); Jessica Montgomery (Second Clerk); Xameerah Malik (Senior Committee Specialist); Victoria Charlton (Committee Specialist); Darren Hackett (Senior Committee Assistant); Julie Storey (Committee Assistant); Henry Ayi-Hyde (Committee Office Assistant); and Nick Davies (Media Officer). Contacts All correspondence should be addressed to the Clerk of the Science and Technology Committee, Committee Office, 14 Tothill Street, London SW1H 9NB. The telephone number for general inquiries is: 020 7219 2793; the Committee’s e-mail address is: [email protected]. Clinical trials 1 Contents Report Page Summary 3 1 Introduction 5 2 Regulation and governance of UK trials 8 What are clinical trials? 8 Regulatory and governing bodies for UK trials 10 The European Clinical Trials Directive 11 3 Barriers to conducting trials in the UK 13 Introduction 13 European barriers to conducting a clinical trial 13 The Clinical Trials Directive 13 The proposed Clinical Trials Regulation 15 UK barriers to conducting a clinical trial 17 Regulatory and governance complexity 17 NHS research and development approval 21 Monitoring NHS Trust performance 22 Patient recruitment 23 The Clinical Trials Gateway 26 4 Clinical trial transparency 30 The need for trial transparency 30 The four levels of clinical trial transparency 34 Level 1: Trial registration 34 Level 2: Summary-level trial results 36 Level 3: Clinical study reports 38 Level 4: Individual patient-level data 41 Past initiatives to increase clinical trial transparency 46 The EU Clinical Trials Register and ClinicalTrials.gov 46 Public and charitable grant requirements 48 The International Committee of Medical Journal Editors 50 Current initiatives to increase clinical trial transparency 50 The EU Clinical Trials Regulation 50 The European Medicines Agency 51 The Health Research Authority 52 Industry-led initiatives 54 The AllTrials campaign 55 Value-based pricing and the renegotiation of the PPRS 56 Incorporating emerging evidence into clinical practice 57 5 Conclusions 59 Conclusions and recommendations 60 2 Clinical trials Formal Minutes 67 Witnesses 68 List of printed written evidence 69 List of additional written evidence 69 List of Reports from the Committee during the current Parliament 71 Clinical trials 3 Summary Clinical trials are the experimental foundation on which modern medicine is built. Trials also make a significant contribution to the UK economy and can provide patients with an important means of accessing the most exciting and innovative new treatments, before they reach the market. Unfortunately, in recent years the number of trials taking place in the UK has fallen steeply. This is partly due to the European Clinical Trials Directive (CTD), which since 2001 has posed a significant barrier to those wishing to conduct a trial in the European Union, and the ongoing revision of which we keenly welcome. However, the CTD aside, a unique regulatory and governance landscape means that the UK remains a particularly challenging place in which to conduct a clinical trial. To date, the Government has failed to eliminate the biggest barrier to initiating a trial in the UK—the requirement for numerous, and potentially duplicate, governance approvals from participating NHS organisations. The newly formed Health Research Authority (HRA) was created to make it easier to conduct research in the NHS, but we have been unable to judge whether it has been successful in achieving this objective as the necessary performance indicators are not currently in place. We were also concerned to find that some important stakeholders are only dimly aware of the HRA and its intended role. In addition, despite positive public attitudes towards medical research, it is difficult for the public to find out about potential research opportunities and Government efforts to rectify this through the re-launch of the UK Clinical Trials Gateway have been only partially successful. While we are confident that the Government is aware of these problems and the need to resolve them, its promises have yet to be matched by effective action. More can and should be done to make the UK a more attractive location for clinical trials. Another key focus of our inquiry has been the issue of clinical trial transparency. We consider that information relating to trials should be shared in a way that is accessible, assessable, intelligible and usable, and we have differentiated in our recommendations between four distinct levels of trial transparency: a) Universal trial registration is crucial to increasing transparency and, in future, all clinical trials conducted in the UK, and all trials related to treatments used by the NHS, should be registered. We extend this recommendation to past trials, and urge the Government to support the retrospective registration of all trials conducted on treatments currently in use by the NHS. b) It is also important that summary-level trial results are made public, and we do not accept the argument that it is not possible to publish “negative” results in peer- reviewed scientific journals. We recommend that trial registration and publication of summary-level results be made contractual requirements for all publicly-funded trials, including those covered by the Charity Research Support Fund, and urge the Government to conduct a retrospective audit of all large public trial grants awarded 4 Clinical trials since 2000 to ensure that they have been registered and published. c) It would be unduly burdensome to mandate that full trial reports—clinical study reports (CSRs)—be produced for non-commercial trials. However, in cases where they are already produced for regulatory reasons, CSRs can make a useful contribution to the scientific literature. Once a regulatory decision has been reached, there is no compelling reason why CSRs should not be placed in the public domain, with identifiable patient data redacted. d) We are not in favour of placing anonymised individual patient-level data (IPD) in the public domain in an unrestricted manner, as the risk to patient confidentiality is too great. Instead, specific individuals should be provided with controlled access to IPD through carefully managed and secure “safe havens”. Access should be facilitated by an independent “gatekeeper”, responsible for ensuring that data is handled responsibly and in a way that makes a useful contribution to scientific knowledge. We consider the current lack of trial transparency to be unacceptable and we have not been impressed by the Government’s efforts to resolve this problem to date. We ask the Government to enhance its efforts to increase transparency and to consider the recommendations of this Report in preparing its response to the European Medicines Agency’s ongoing consultation on access to clinical trial data. Clinical trials 5 1 Introduction 1. The UK has long been a world leader in the field of medical research. Since the birth of the pharmaceutical industry over a century ago, only the USA has discovered and developed
Load more

Recommended publications
  • Shiatsu and Cancer
    SHIATSU AND CANCER As with many other complementary therapies a major benefit for people affected by cancer is having time to talk, be listened to and heard in a safe environment. The shiatsu practitioner is trained to relate to people as individuals and assess their physical, mental, emotional and spiritual needs – essential in recovery from cancer. The power of touch used in shiatsu should never be underestimated. Shiatsu can offer valuable support from the point of diagnosis, immediately after surgery and throughout radiotherapy and chemotherapy. Once treatment is finished, shiatsu sessions can aid recovery, help to renew energy and motivate people to take responsibility for their wellbeing. Shiatsu offers a drug free solution to reduce side effects such as pain, nausea and lethargy associated with surgery, radiotherapy and chemotherapy and may help to reduce hot flushes in hormone therapy. Shiatsu restores and balances energy levels and triggers the relaxation response easing stress and tension in the body and mind and encouraging restful sleep. Shiatsu facilitates emotional release without the need to ask searching questions, helping to reduce levels of fear and anxiety, dissipate anger and frustration and assist the grieving process. Shiatsu moves the lymph helping to minimise the risk of lymphoedema. Shiatsu assists with the detoxification process. Shiatsu helps to restore hormonal balance in hormone related cancers Shiatsu encourages correct posture, breathing, stretching and exercise Shiatsu may help to boost the immune response Shiatsu improves circulation and enhances wellbeing Shiatsu awakens the spirit and inspires hope for the future. Shiatsu helps people to get back in control, encourages self management and empowers people to take responsibility for their healing and well-being, thereby improving their quality of life.
    [Show full text]
  • Eurohealth Vol 13 No 3 MENTAL HEALTH ECONOMICS
    Eurohealth RESEARCH • DEBATE • POLICY • NEWS Volume 13 Number 3, 2007 Making the economic case for mental health in Europe France: Health promotion for migrants Intergovernmental relations in Italian health care Health inequalities in the decentralised Spanish health care system Migration of Flemish doctors to the Netherlands • Romania: Pharmaceutical pricing and reimbursement Austria: Electronic health record development • Institutional and community care for older people in Turkey Eurohealth A timely opportunity for Europe LSE Health, London School of Economics and Political The European Commission has just published its new Science, Houghton Street, London WC2A 2AE, United Kingdom C Health Strategy ‘Together for Health: A Strategic fax: +44 (0)20 7955 6090 Approach for the EU 2008–2013’. Building on current www.lse.ac.uk/LSEHealth work, this Strategy aims to provide, for the first time, Editorial Team an overarching strategic framework spanning core EDITOR: issues in health, as well as in ‘health in all policies’ David McDaid: +44 (0)20 7955 6381 and global health issues. email: [email protected] O FOUNDING EDITOR: Elias Mossialos: +44 (0)20 7955 7564 The explicit inclusion of the promotion of mental, as email: [email protected] well as physical, health is a timely reminder of the DEPUTY EDITORS: importance of looking at health holistically. Poor Sherry Merkur: +44 (0)20 7955 6194 mental health affects more than 130 million Europeans email: [email protected] Philipa Mladovsky: +44 (0)20 7955 7298 M at a cost to every European household of more than email: [email protected] € 2,000 per annum.
    [Show full text]
  • A Day to Remember
    THE Independent Autumn 2010 Adayto remember Installing our new Chancellor – Page 6 Interview: Karol Sikora Page 8 Dickens Dinner An invitation to celebrate 150 years of Great Expectations Page 5 www.buckingham.ac.uk Annual Fund Help us remain No 1 in the National Student Survey by donating to the following projects: • Multimedia Centre • Video Equipment • Bursaries & Prizes • Hardship Fund Thank you to everyone whose donations have enabled the Annual Fund to successfully contribute to the following projects: • Campus Radio Station • Memorial Garden • The Cellars, Verney Park • BSc in Business Enterprise Prize • University Minibus • Wellness Centre • SU Music Equipment To Donate Go To https://extranet.buckingham.ac.uk/alumnet/ubf-aaf.aspx ALUMNI Annual Fund 2 Autumn 2010 Contents 3 Welcome Welcome to the Comment 4 From the Vice-Chancellor autumn issue This year, 2010, has been a good University News 5 one for the university because Great Dinner Expected; for the fifth year running Most Satisfied Students; Buckingham hit the top spot for student satisfaction in the Afternoon Tea at the House National Student Survey. It is a of Lords; At Home with your spectacular achievement and VC; New Faces; Leavers our thanks go to students and staff for the support and effort involved in keeping us at Looking to the Future Number One. 7 Installation of the new The university is changing all the time and experienced a surge in student numbers in September, Chancellor doubling its intake compared with last year. Part of the reason, we think, is our position in the league tables - we entered the league table Feature – Escape from the in The Independent newspaper for the first time this year coming in at 8 Day Job 20th position, and we also appear this year in the teaching training league table, in fifth position.
    [Show full text]
  • Public Attitudes to Science 2011: Literature Review
    Contents Introduction .....................................................................................1 Key Findings....................................................................................2 1. Defining the Sciences ........................................................................ 2 2. Levels of Understanding of the Sciences ........................................... 3 3. Engagement with the Sciences .......................................................... 4 4. Trust in the Sciences.......................................................................... 5 5. The Place of the Sciences in Society ................................................. 7 6. Attitudes towards Specific Scientific Issues...................................... 10 7. Attitudes by Demographic Group ..................................................... 15 8. Conclusions...................................................................................... 18 Appendices ....................................................................................19 Appendix A: Inclusion Criteria .................................................................. 19 Appendix B: Review Pro Forma ............................................................... 20 Appendix C: Index of Main Sources......................................................... 21 References.....................................................................................23 Public Attitudes to Science 2011: Literature Review Introduction This report presents the findings of a literature
    [Show full text]
  • Side Effects
    WARNING: SIDE EFFECTS A check-up on the federal health law United States Senate 112th Congress Senator Tom Coburn, M.D. Senator John Barrasso, M.D. March 2012 0 Contents Introduction………………….……………………………………………………………………………………..2 1. Millions of Americans Could Lose Their Health Insurance Plan……………………………...5 2. Hundreds of Billions of Dollars of Tax Hikes………………………………………………………….9 3. New Insurance Rule Increases Costs, Reduces Choices…………………………………………11 4. Data Confirms Law Is a Government-Takeover of Health Care……………………………...16 5. Findings from New Taxpayer-Funded Research Institute Could Be Used to Deny Payment for Patients’ Care………………………………………………20 6. New Medicare Bureaucracy Empowered………………….………………………………………...27 7. New Insurance Cooperatives to Waste Taxpayers’ Dollars……………………….………….30 8. Device Tax Stifles Innovation…………………………………………………………………………..…34 1 Introduction Two years ago, supporters of the President’s health care law said Congress needed to pass the health bill so the American people could find out what was in it.1 After the President signed the bill into law, supporters guaranteed that “as people learn about the bill….it’s going to become more and more popular.”2 Over the past twenty four months, American families have learned more about the President’s health care law and do not like what they see. Higher insurance premiums. A coming state budget-busting Medicaid expansion. Fewer choices. Less freedom and more government interference. Cuts to Medicare by unelected government bureaucrats. Thousands of pages of regulations. An unconstitutional mandate to buy health insurance. Penalties on employers threatening job creation. Billions of dollars in tax hikes and, once fully implemented, $2.6 trillion in new health care spending. It’s no wonder that a majority of Americans oppose the law today.3 In fact, poll after poll shows that a majority of Americans want the Supreme Court to overturn the law.4 As practicing physicians, we believed – long before Congress passed the health spending law – that the health care law did not represent real health care reform.
    [Show full text]
  • Professor Karol Sikora
    THE MAGAZINE FOR DULWICH COLLEGE ALUMNI FEATURING PROFESSOR KAROL SIKORA With reflections on the pandemic and its impact on cancer PLUS KYLE KARIM AT LEGO AND THE ORIGINS OF SOCCER AT DC WELCOME TO THE MAGAZINE FOR DULWICH COLLEGE ALUMNI PAGE 03 Meet the Team Trevor Llewelyn Matt Jarrett (72-79) Hon Secretary of Director of Development the Alleyn Club As I write this editorial the College is currently In the last edition of OA I hoped that our new format closed to all but the children of key workers. It is would allow us to look in greater depth at the only the third time in the school’s long history that lives and careers of OAs. That we have been able this has happened and two of those have been in to do with interviews with sailor Mark Richmond, response to Covid 19. The only other time our gates opera singer Rodney Clarke and Kyle Karim who Joanne Whaley have been shut was during the Second World War as Director of Marketing for Lego may, by his own Kathi Palitz when we temporarily moved out of the capital in admission, just have the best job in the world. Alumni & Parent Database and Operations order to share the facilities of Tonbridge School. It Relations Manager was not a success and the boys soon returned to Like much of the country very little competitive sport Manager London and in so doing Dulwich became one of the took place during the summer and our reporting very few public schools not to be evacuated for the reflects this.
    [Show full text]
  • Warning: Side Effects
    WARNING: SIDE EFFECTS A check-up on the federal health law United States Senate 112th Congress Senator Tom Coburn, M.D. Senator John Barrasso, M.D. March 2012 0 Contents Introduction………………….……………………………………………………………………………………..2 1. Millions of Americans Could Lose Their Health Insurance Plan……………………………...5 2. Hundreds of Billions of Dollars in Tax Hikes………………………………………………………….9 3. New Insurance Rule Increases Costs, Reduces Choices…………………………………………11 4. Data Confirms Law Is a Government-Takeover of Health Care……………………………...16 5. Findings from New Taxpayer-Funded Research Institute Could Be Used to Deny Payment for Patients’ Care………………………………………………20 6. New Medicare Bureaucracy Empowered………………….………………………………………...27 7. New CO-Ops Expected to Waste Taxpayers’ Dollars…………………………………………….30 8. Device Tax Stifles Innovation…………………………………………………………………………..…34 1 Introduction Two years ago, supporters of the President’s health care law said Congress needed to pass the health bill so the American people could find out what was in it.1 After the President signed the bill into law, supporters guaranteed that “as people learn about the bill….it’s going to become more and more popular.”2 Over the past twenty four months, American families have learned more about the President’s health care law and do not like what they see. Higher insurance premiums. A coming state budget-busting Medicaid expansion. Fewer choices. Less freedom and more government interference. Cuts to Medicare by unelected government bureaucrats. Thousands of pages of regulations. An unconstitutional mandate to buy health insurance. Penalties on employers threatening job creation. Billions of dollars in tax hikes and, once fully implemented, $2.6 trillion in new health care spending.
    [Show full text]
  • Getting to the Future First
    Getting to the Future First Susan Greenfield Thinker in Residence 2004-2005 Susan Greenfi eld | Getting to the Future First Getting to the Future First Prepared by Baroness Professor Susan Greenfi eld Department of the Premier and Cabinet c/- GPO Box 2343 Adelaide SA 5001 January 2006 ©All rights reserved – Crown – in right of the State of South Australia ISBN 0-9752027-7-4 www.thinkers.sa.gov.au 1 Baroness Professor Foreword Susan Greenfi eld Baroness Professor Susan Greenfi eld is a Baroness Professor Susan Greenfi eld is making She has put forward a number of other pioneering scientist, an entrepreneur, a an outstanding contribution to South Australia valuable ideas as part of the recommendations communicator of science and a policy adviser. – and the public’s understanding of science. in this report, which I commend to all those interested in improving science literacy and Susan has long been regarded as a world- She came to us with a reputation as being awareness. leading expert on the human brain, and is one of the most infl uential and inspirational widely known for her research into Parkinson’s women in the world – as both a pioneering I thank Baroness Greenfi eld for her hard work and Alzheimer’s disease. She has received a life scientist and a gifted communicator. and generosity of spirit, and for continuing to peerage and a CBE in the United Kingdom. make a difference to South Australia. While in Adelaide, as our Thinker in Residence, Susan is the fi rst woman to lead the she shared her insights into the human brain prestigious Royal Institution of Great Britain – how it works, how it copes with ageing and and also holds the positions of Senior Research how it responds to drugs, for example.
    [Show full text]
  • RAGE Reportv15.Qxp
    Yesterday’s women The story of R.A.G.E. Researched and written by Bec Hanley and Kristina Staley, TwoCan Associates Yesterday’s Women: the story of R.A.G.E. Yesterday’s Women: the story of R.A.G.E. This story is dedicated to all those who have supported Yesterday’s Women is a report commissioned by Macmillan Cancer the R.A.G.E. campaign over the past 15 years. We’d like Support and researched and written by TwoCan Associates. It aims to tell the story of R.A.G.E. (Radiotherapy Action Group Exposure), drawing on to particularly mention Liz Gebhardt, Carole Hunter, interviews with R.A.G.E. members and other people who played a part in Valerie Eldridge and Lorna Patch, R.A.G.E. Committee their history, as well as a review of the documents kept by the people members who sadly have passed away and for whom who were interviewed. Yesterday’s Women has been written too late. Other parties are permitted to make use of this report independently of Macmillan Cancer Support. However Macmillan Cancer Support and TwoCan Associates do not endorse, support or take responsibility for any use of the report by any individual or organisation or any reliance on the material contained in it. If Macmillan Cancer Support uses the report for its own purposes, any such use will be clearly stated to be Macmillan Cancer Support endorsed activity. © Macmillan Cancer Support/ R.A.G.E. October 2006 2 3 Yesterday’s Women: the story of R.A.G.E.
    [Show full text]
  • Bringing STEM Experts Into Your Classroom a Teaching and Learning Guide
    Bringing STEM Experts into Your Classroom A Teaching and Learning Guide Information and advice for primary schools, and scientists and engineers, wishing to develop a partnership to support primary science and technology Bringing STEM Experts into Your Classroom This Teaching and Learning Guide begins with an overview of some local programmes enabling upper primary pupils to interact with STEM practitioners from industry, academia and government. These programmes include Civil Engineers in Primary Schools (supported by the Institution of Civil Engineers), Science Expressions (supported by the Astra-Zeneca Science Teaching Trust, and W5), STEM Experts in Primary Schools (supported by the Primary Science Teaching Trust (PSTT), and Sentinus), Physical Scientists from the World Around Us (supported by the Royal Society of Chemistry, and the Institute of Physics in Ireland), Primary BioSciences and Primary Life Sciences (supported by the Wellcome Trust), Primary Food Sciences (in association with the Institute for Global Food Security at Queen’s University Belfast). The essential feature of these programmes is that they provide continuing interaction between a working scientist or engineer and a primary school teacher and pupils over a period of time leading to a specific outcome or event, and provide a foundation for pupils to make appropriate course and career decisions later. As each section of this Guide is self-contained, there is some repetition between sections The programmes described in this paper were supported by: the Institute for Global Food Security at Queen’s University Belfast, the Institute of Physics in Ireland, the Institution of Civil Engineers, the Primary Science Teaching Trust (formerly the Astra Zeneca Science Teaching Trust), the Royal Society of Chemistry, Sentinus, the School of Medicine, Dentistry and Biomedical Sciences at Queen’s University Belfast, W5, and the Wellcome Trust.
    [Show full text]
  • SPEAK for YOURSELF Editorial
    MARCH 2006 OPEN UNIVERSITY SWR INTERVIEW CAREERS OU students Scott Kelly: The pros consider the to infinity and cons of end of an era and beyond doing a PhD nexusnews The Student Newsletter of the Institute of Physics PHYSICISTS AND THE MEDIA SPEAK FOR YOURSELF Editorial Letter from the editor Institute of Physics, 76 Portland Okay, so the cover is a little misleading. Instead of “Speak for Place, London W1B 1NT, UK. Tel: +44 (0)20 7470 4800 yourself” it should probably read “How to work in harmony with Fax: +44 (0)20 7470 4848 journalists to achieve a less misleading interpretation of your scientific views”. But that’s not as snappy. Besides, I bet the one we Samir Dawoud Student liaison officer and chose grabbed your attention! editor of Nexus News Joking aside, being unable to express your ideas and views to [email protected] someone without being misinterpreted is frustrating – whether it’s your friends, your family or even journalists. The Science Media Sarah Connolly Member support officer Centre, in conjunction with the charitable trust Sense About Science, [email protected] offers valuable advice on how to work effectively with the press from those on both sides of the fence. Check out Frances Downey’s report on p8 about a recent Voice of Young Science media day, and pick up Vishanti Lall some invaluable tips. Institute careers adviser [email protected] Elsewhere, the Imperial College Astronomy Society presents a fascinating interview with NASA astronaut Scott Kelly (p5) who has some inspirational advice for young scientists. Curiously, Kelly’s identical twin brother is also a NASA astronaut, who appeared in a E-mail [email protected] if you have any queries about your subscription, need to recent issue of Nexus News! It sounds like a bad excuse for me to register a change of address or have missed a recycle material but I promise it’s true! copy of Physics World.
    [Show full text]
  • Living Well Right to the End
    1 Special Interest Group for Philosophy and Ethics Living Well Right to the End Rydal Hall, June 26th to 29th, 2017 2 Contents Living Well Right to the End Introduction 4 Peter Wemyss-Gorman Living with the uncertainty of Cancer 6 Karol Sikora Taking Care of the person in chronic illness 20 Sara Booth Creative approaches to palliative care 35 Kate Binnie Living to die 43 Andy Graydon Coming alive at last 52 Jeremy Swayne To let the patient live and die with dignity 57 Sophie-Freda Borge Contemplative care 65 Narapa Steve Johnson Healing while dying 77 Emmylou Rahtz My recent training in hypnosis 87 Tim Johnson Valuing end of life care 90 Peter Bennett Homeward bound 96 Gillian Bartram 3 Editor Peter Wemyss-Gorman Retired Consultant in Pain Medicine Contributors Karol Sikora, Consultant Oncologist and Dean, University of Buckingham Medical School Sara Booth Honorary Consultant in Palliative Care, Cambridge University Hospitals NHS Trust and Associate Lecturer, Cambridge University Kate Binnie Music therapist and teacher of yoga and mindfulness in palliative care Father Andy Graydon Catholic Priest and hospital chaplain, working in palliative care, mental health and chronic pain Jeremy Swayne Retired GP, homoeopathist and Anglican priest Sophie-Freda Borge Nurse Specialist in Anaesthetics and Palliative Care, Norway Narapa Steve Johnson Buddhist Chaplain and Mindfulness Teacher Emmylou Rahtz Associate Research Fellow, Exeter University Tim Johnson Consultant in Pain Medicine, Salford Peter Bennett Retired senior civil servant, Department of Health. Associate Faculty Member. Science Policy Research Unit, Sussex University Gillian Bartlam Hypnotherapist and Psychotherapist. Professional singer 4 Introduction Peter Wemyss-Gorman I first suggested the theme of this meeting to our steering committee last year after I read the wonderful book Being Mortal by Atul Gawande.
    [Show full text]